window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

RNA therapeutics

  • Biotech,Funding,Genetic Diseases,Mergers & Acquisitions,Research & Development,RNA Therapeutics

    Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform

    Circio has raised NOK 250 million in a significantly oversubscribed [...]

    April 8, 2026
  • CDMOs & Manufacturing,Drug Development,Manufacturing,RNA Therapeutics

    Codexis signs siRNA manufacturing deal for cardiovascular programme

    Codexis has signed an agreement to manufacture siRNA for a [...]

    March 23, 2026
  • Infectious Diseases,Research & Development,RNA Therapeutics

    Circio and University of Texas Medical Branch partner on infectious disease research using circular RNA

    Circio has entered a research collaboration with the University of [...]

    February 9, 2026
  • Drug approval,Immunology,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs,RNA Therapeutics

    Donidalorsen granted EU approval for hereditary angioedema prevention

    Donidalorsen has received European Union marketing authorisation for the routine [...]

    January 23, 2026
  • Biotech,Drug Development,Global health,Partnerships & Funding,RNA Therapeutics

    Hongene Biotech receives Gates Foundation grant for patent-free mRNA cap analogs

    Hongene Biotech has received a grant from the Gates Foundation [...]

    January 22, 2026
  • Chronic diseases,Drug Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development

    Ochre Bio and GSK complete research phase with large-scale human liver genomics datasets

    Ochre Bio has completed the research phase of its collaboration [...]

    November 18, 2025
  • Biologics & Biosimilars,Clinical Development,Genetic Diseases,Rare Diseases,Research & Development,RNA Therapeutics

    Tevard Biosciences shows full-length protein rescue in Duchenne muscular dystrophy and dilated cardiomyopathy models

    Tevard Biosciences has presented new preclinical data demonstrating the potential [...]

    October 2, 2025
  • Cell & Gene Therapy,Clinical Development,Oncology,Technology and platforms

    N4 Pharma and SRI demonstrate targeted Nuvec delivery to lung cancer cells

    N4 Pharma has reported new data from its collaboration with [...]

    September 24, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    September 25, 2025
  • Cell & Gene Therapy,Pharmaceuticals and therapeutics,Research & Development,RNA Therapeutics,Technology and platforms

    N4 Pharma advances targeted RNA delivery with SRI collaboration

    N4 Pharma plc, the UK biotech developing its proprietary Nuvec® [...]

    September 23, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top